Mebhydrolin: Difference between revisions
Brian Blank (talk | contribs) No edit summary |
(No difference)
|
Revision as of 19:05, 10 June 2009
| Clinical data | |
|---|---|
| Synonyms | Incidal, Omeril, diazolin, Fabahistin, mebhydrolin napadisylate, mebhydroline 1,5-naphthalenedisulfonate[2] |
| Pregnancy category |
|
| Routes of administration | oral[1] |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C19H20N2[4] |
| Molar mass | 276.376 g/mol |
| 3D model (JSmol) | |
| |
|
WikiDoc Resources for Mebhydrolin |
|
Articles |
|---|
|
Most recent articles on Mebhydrolin Most cited articles on Mebhydrolin |
|
Media |
|
Powerpoint slides on Mebhydrolin |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Mebhydrolin at Clinical Trials.gov Clinical Trials on Mebhydrolin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Mebhydrolin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Mebhydrolin Discussion groups on Mebhydrolin Patient Handouts on Mebhydrolin Directions to Hospitals Treating Mebhydrolin Risk calculators and risk factors for Mebhydrolin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Mebhydrolin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Mebhydrolin (INN) or mebhydroline is an antihistamine. It is not available in the United States, but it is in various other countries. It is also called Bexidal (BD) and Diazolin (RU). It is used for symptomatic relief of allergic symptoms caused by histamine release, including nasal allergies and allergic dermatosis.
Mebhydrolin has been shown to enhance the performance-deficit effects of alcohol.[5]
References
- ↑ 1.0 1.1 "FABAHISTIN 50 mg (Tablets)" (HTML). South African Electronic Package Inserts. 1970-09. Retrieved 2007-03-02. Check date values in:
|date=(help) - ↑ "Mebhydroline" (HTML). National Library of Medicine - Medical Subject Headings. US National Institutes of Health, National Library of Medicine. Retrieved 2007-03-02.
- ↑ "Diazoline" (HTML). National Library of Medicine - Medical Subject Headings. US National Institutes of Health, National Library of Medicine. Retrieved 2007-03-02.
- ↑ "Mebhydrolin chemical information" (HTML). PubChem. Retrieved 2007-03-02.
- ↑ Franks, HM (1981-10-31). "Interaction between ethanol and antihistamines: 3. mebhydrolin" (HTML). Med J Aust. Retrieved 2007-03-02. Unknown parameter
|coauthors=ignored (help)
- Pages with script errors
- CS1 errors: dates
- Pages with citations using unsupported parameters
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles with erroneous molar mass calculations
- Chemical articles with unknown parameter in Infobox drug
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Antihistamines
- Indoles